[KM 2210 therapy for chronic lymphocytic leukemia].
作者信息
Mori M, Murai Y, Miwa A, Fukayama M, Ikebuchi K, Nakamura N, Kaise M
出版信息
Gan No Rinsho. 1983 Dec;29(15):1788-90.
PMID:6689433
Abstract
Two previously untreated patients with chronic lymphocytic leukemia (CLL) were treated with KM 2210 50 mg/day orally for 30 and 14 days, respectively. They showed good responses: One achieved complete, the other partial, remission. Toxicity was not observed in either patient. KM 2210 was thought to be an effective drug for CLL.
摘要
相似文献
1
[KM 2210 therapy for chronic lymphocytic leukemia].
Gan No Rinsho. 1983 Dec;29(15):1788-90.
2
[Clinical trial of bestrabucil (KM 2210) on hematopoietic malignancies].[Bestrabucil（KM 2210）治疗造血系统恶性肿瘤的临床试验]
Gan To Kagaku Ryoho. 1986 Jun;13(6):2155-9.
3
[Early phase II trial of bestrabucil in hematological malignancies].[贝司他布昔用于血液系统恶性肿瘤的II期早期试验]
Gan To Kagaku Ryoho. 1986 Jun;13(6):2216-22.
4
5
[Phase II study of chlorambucil in patients with hematological malignancies].苯丁酸氮芥治疗血液系统恶性肿瘤患者的II期研究
Gan To Kagaku Ryoho. 1987 Sep;14(9):2672-5.
6
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.苯达莫司汀与苯丁酸氮芥用于既往未治疗的慢性淋巴细胞白血病患者的Ⅲ期随机研究。
J Clin Oncol. 2009 Sep 10;27(26):4378-84. doi: 10.1200/JCO.2008.20.8389. Epub 2009 Aug 3.
7
[Phase II study of prednimustine in follicular lymphoma and chronic lymphocytic leukemia].
Gan To Kagaku Ryoho. 1987 Jan;14(1):173-8.
8
[Effect of Prednimustine (Leo 1031) in chronic lymphatic leukemia].
Osterr Z Onkol. 1977;3(5-6):155-9.
9
Biweekly chlorambucil treatment of lymphocytic lymphoma.淋巴细胞性淋巴瘤的苯丁酸氮芥双周疗法。
Cancer Clin Trials. 1980;3(4):329-36.
10
Treatment of chronic lymphocytic leukemia and lymphosarcoma with a new chlorambucil ester of prednisolone (Leo 1031) (NSC-134087).用一种新的泼尼松龙苯丁酸氮芥酯（Leo 1031，NSC - 134087）治疗慢性淋巴细胞白血病和淋巴肉瘤。
J Surg Oncol. 1975;7(6):457-60. doi: 10.1002/jso.2930070604.
Zotero 插件